J
Josep Costa
Researcher at University of Girona
Publications - 248
Citations - 10814
Josep Costa is an academic researcher from University of Girona. The author has contributed to research in topics: Delamination & Hepatitis C virus. The author has an hindex of 43, co-authored 235 publications receiving 9667 citations. Previous affiliations of Josep Costa include Carlos III Health Institute & Benemérita Universidad Autónoma de Puebla.
Papers
More filters
Journal ArticleDOI
Accurate simulation of delamination growth under mixed-mode loading using cohesive elements: Definition of interlaminar strengths and elastic stiffness
TL;DR: In this paper, a methodology for predicting accurately the propagation of delamination under mixed-mode fracture with cohesive elements is proposed, where relations between the interlaminar strengths and the penalty stiffness are proposed which ensure a correct energy dissipation when delamination propagates.
Journal ArticleDOI
Simulation of delamination in composites under high-cycle fatigue
TL;DR: In this article, a damage model for the simulation of delamination propagation under high-cycle fatigue loading is proposed, based on a cohesive law that links fracture and damage mechanics to establish the evolution of the damage variable in terms of the crack growth rate.
Journal ArticleDOI
Determination of the critical size of a statistical representative volume element (SRVE) for carbon reinforced polymers
TL;DR: In this article, the authors established the minimum size of a statistical volume element for a typical carbon fiber reinforced polymer and showed that it is δ = L/R = 50 (L the side of the element and R the fibre radius).
Journal ArticleDOI
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
Alberto Sanchez-Fueyo,Antoni Rimola,Luis Grande,Josep Costa,Antoni Mas,Miguel Navasa,Isabel Cirera,José María Sánchez-Tapias,Juan Rodés +8 more
TL;DR: The data suggest that in selected liver transplant recipients, posttransplantation HBV vaccination may be a useful and cost‐effective strategy in the prophylaxis of HBV recurrence, allowing the discontinuation of life‐long HBIG treatment.
Journal ArticleDOI
The Incidence of Human Parvovirus B19 Infection during Pregnancy and Its Impact on Perinatal Outcome
Eduard Gratacós,Pere-Joan Torres,Josep Vidal,Eugenia Antolin,Josep Costa,M. T. Jimenez de Anta,Vicenç Cararach,P. L. Alonso,Albert Fortuny +8 more
TL;DR: Evidence is provided that although acute parvovirus infection may occur relatively commonly during pregnancy, an adverse fetal outcome is a rare complication.